FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
· manilatimes.net
First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia
First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia
Silver Spring, MD, July 17, 2026 (GLOBE NEWSWIRE) -- Th...